Free Trial

Protagenic Therapeutics (PTIXW) Competitors

$0.06 +0.01 (+29.41%)
As of 07/7/2025 10:24 AM Eastern

PTIXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Protagenic Therapeutics stock or one of its competitors? The main competitors of Protagenic Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Protagenic Therapeutics vs. Its Competitors

Protagenic Therapeutics (NASDAQ:PTIXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Protagenic TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protagenic TherapeuticsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Protagenic Therapeutics Neutral
180 Life Sciences Neutral

Summary

Protagenic Therapeutics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Protagenic Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTIXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTIXW vs. The Competition

MetricProtagenic TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.89M$5.52B$9.02B
Dividend YieldN/A3.74%5.24%4.07%
P/E RatioN/A3.3727.2220.04
Price / SalesN/A4,413.20380.3292.37
Price / CashN/A13.1926.2128.59
Price / BookN/A42.467.945.55
Net IncomeN/A-$92.79M$3.17B$248.49M
7 Day PerformanceN/A8.85%1.81%4.87%
1 Month PerformanceN/A3.16%1.28%6.63%
1 Year PerformanceN/A183.58%33.57%20.38%

Protagenic Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTIXW
Protagenic Therapeutics
N/A$0.06
+29.4%
N/AN/A$0.00N/A0.002Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A-4.6%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.12
-7.7%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-36.2%$0.00$585.60M0.004Positive News
AMPE
Ampio Pharmaceuticals
0.1435 of 5 stars
N/AN/A-96.0%$0.00N/A0.0020Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+157.7%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
-2.0%
N/AN/A$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.06
-17.1%
N/A-71.1%$0.00N/A0.008

Related Companies and Tools


This page (NASDAQ:PTIXW) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners